{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:06:58Z","timestamp":1788847618546,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd011064","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000}}],"reference-count":70,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011064.pub2","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T04:55:17Z","timestamp":1601528117000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Calcium channel blockers for people with chronic kidney disease requiring dialysis"],"prefix":"10.1002","volume":"2020","author":[{"given":"George A","family":"Mugendi","sequence":"additional","affiliation":[{"name":"Pharmaceutics and Pharmacy Practice, School of Pharmacy; University of Nairobi; Nairobi Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence M","family":"Mutua","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology; University of Manitoba; Winnipeg Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Natale","sequence":"additional","affiliation":[{"name":"Department of Emergency and Organ Transplantation; University of Bari; Bari Italy"},{"name":"Sydney School of Public Health; The University of Sydney; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonya M","family":"Esterhuizen","sequence":"additional","affiliation":[{"name":"Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Faculty of Medicine and Health Sciences; Stellenbosch University; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni FM","family":"Strippoli","sequence":"additional","affiliation":[{"name":"Department of Emergency and Organ Transplantation; University of Bari; Bari Italy"},{"name":"Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia"},{"name":"Sydney School of Public Health; The University of Sydney; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD011064.pub2-BIB0001|cit1","first-page":"A190","article-title":"Impact of ACE inhibitors on erythropoiesis in haemodialysis (HD) populations [abstract]","volume":"12","author":"Albitar","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011064.pub2-BIB0002|cit2","first-page":"S515","article-title":"Enalapril versus nifedipine in patients on maintenance haemodialysis (HD) with erythropoietin-induced hypertension (HT) [abstract]","volume":"3","author":"Albitar","year":"1997","journal-title":"Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD011064.pub2-BIB0003|cit3","article-title":"Left ventricular mass regression in patients with end-stage renal disease [abstract no: 71]","volume":"55","author":"Das","year":"2003","journal-title":"Indian Heart Journal"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD011064.pub2-BIB0004|cit4","first-page":"711","article-title":"Effects of blood pressure lowering and antihypertensive drug class on cardiovascular events of hemodialysis patients results from HEmodialysis Angiotensin-inhibition Rescue Trial (HEART) [abstract no: W515]","volume":"18","author":"Nakao","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Nov","key":"10.1002\/14651858.CD011064.pub2-BIB0005|cit5","first-page":"40A","article-title":"Effects of blood pressure lowering and antihypertensive drug class on cardiovascular events of hemodialysis patients: results from HEmodialysis Angiotensin-inhibition Rescue Trial (HEART) [abstract no: SA-FC183]","volume":"14","author":"Nakao","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD011064.pub2-BIB0006|cit6","first-page":"iv436","article-title":"Effects of perindopril, amlodipine and combination of perindopril and amlodipine on left ventricular mass and diastolic function in non-diabetic haemodialysis patients with hypertension [abstract no: MP408]","volume":"21","author":"Kozlova","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD011064.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1161\/01.CIR.82.1.105","article-title":"Salt and water retention and calcium blockade in uremia","volume":"82","author":"London","year":"1990","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD011064.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1161\/01.CIR.90.6.2786","article-title":"Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade","volume":"90","author":"London","year":"1994","journal-title":"Circulation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD011064.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"iii51","DOI":"10.1093\/ndt\/gfx117.MO024","article-title":"Effects of l\/n-type calcium channel blocker cilnidipine on ambulatory blood pressure and blood pressure variability in patients with intradialytic hypertension [abstract]","volume":"32","author":"Fujimoto","year":"2017","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD011064.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/10641963.2018.1445753","article-title":"The effect of an L\/N-type calcium channel blocker on intradialytic blood pressure in intradialytic hypertensive patients","volume":"41","author":"Ito","year":"2019","journal-title":"Clinical & Experimental Hypertension"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD011064.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"iii472","DOI":"10.1093\/ndt\/gfx163.MP121","article-title":"The effect of cilnidipine on intradialytic blood pressure in intradialytic hypertensive patients: A multicenter, prospective, randomized, open-label study [abstract]","volume":"32","author":"Ito","year":"2017","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD011064.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1097\/00005344-199106181-00018","article-title":"Arteriosclerosis and antihypertensive response to calcium antagonists in end-stage renal failure","volume":"18 Suppl 1","author":"Marchais","year":"1991","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD011064.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/00005344-199106185-00005","article-title":"Arteriosclerosis and antihypertensive response to calcium antagonists in end-stage renal failure","volume":"18 Suppl 5","author":"Marchais","year":"1991","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD011064.pub2-BIB0014|cit14","first-page":"368A","article-title":"Trandolapril compared with slow-releasing nifedipine not only reduced mortality but also improved QOL of hypertensive hemodialysis patients [abstract no: A1854]","volume":"10","author":"Nakao","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD011064.pub2-BIB0015|cit15","first-page":"A128","article-title":"Angiotensin II type-1 receptor antagonist losartan has greater anti-fibrotic effect than ACE inhibitor in patients with end stage renal disease [abstract]","volume":"16","author":"Shibasaki","year":"2001","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD011064.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000049060","article-title":"Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease","volume":"90","author":"Shibasaki","year":"2002","journal-title":"Nephron"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD011064.pub2-BIB0017|cit17","first-page":"245A","article-title":"Angiotensin II receptor antagonist suppress left ventricular hypertrophy and fibrosis in patients with end stage renal disease [abstract]","volume":"12","author":"Shibasaki","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD011064.pub2-BIB0018|cit18","first-page":"1992","article-title":"Angiotensin II type 1 antagonist suppress left ventricular hypertrophy and myocardial fibrosis in patient with end stage renal disease (ESRD)","volume":"60","author":"Shibasaki","year":"2002","journal-title":"Nippon Rinsho [Japanese Journal of Clinical Medicine]"},{"issue":"10","key":"10.1002\/14651858.CD011064.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1291\/hypres.28.787","article-title":"Impact of the angiotensin II receptor antagonist, losartan, on myocardial fibrosis in patients with end-stage renal disease: assessment by ultrasonic integrated backscatter and biochemical markers","volume":"28","author":"Shibasaki","year":"2005","journal-title":"Hypertension Research - Clinical & Experimental"},{"issue":"11","key":"10.1002\/14651858.CD011064.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1093\/ndt\/gfn304","article-title":"Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients","volume":"23","author":"Tepel","year":"2008","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011064.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00044011-199700131-00013","article-title":"A comparative study of amlodipine and verapamil in hypertensive patients undergoing haemodialysis","volume":"13","author":"Timio","year":"1997","journal-title":"Clinical Drug Investigation"},{"key":"10.1002\/14651858.CD011064.pub2-BIB0022|cit22","first-page":"870A","article-title":"Effects of amlodipine and ramipril on cardiovascular system in hemodialysis patients [abstract no: PUB407]","volume":"16","author":"Yilmaz","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD011064.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3109\/0886022X.2010.502276","article-title":"Impact of amlodipine or ramipril treatment on left ventricular mass and carotid intima-media thickness in nondiabetic hemodialysis patients","volume":"32","author":"Yilmaz","year":"2010","journal-title":"Renal Failure"},{"key":"10.1002\/14651858.CD011064.pub2-BIB0024|cit24","unstructured":"Yilmaz R Kahraman S Altun B Genctoy G Akinci D Ozer N Effects of amlodipine and ramipril on left ventricular mass index and carotid atherosclerosis in hemodialysis patients [abstract] 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal 2004 352"},{"issue":"12","key":"10.1002\/14651858.CD011064.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1038\/sj.ki.5001983","article-title":"Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis","volume":"70","author":"Aslam","year":"2006","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD011064.pub2-BIB0026|cit26","first-page":"102A","article-title":"The effects of valsartan and amlodipine therapy on oxidative stress and L-arginine metabolism in patients on maintenance hemodialysis: a randomized double-blind crossover study [abstract no: SA-FC092]","volume":"16","author":"Santha","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD011064.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4103\/1319-2442.121274","article-title":"Effects of oral enalapril and verapamil on dialysis adequacy and solute clearance in chronic ambulatory peritoneal dialysis","volume":"24","author":"Atabak","year":"2013","journal-title":"Saudi Journal of Kidney Diseases & Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD011064.pub2-BIB0028|cit28","first-page":"397","article-title":"Effectiveness and tolerability of bisoprolol vs. nifedipine in uremic patients with ischemic cardiopathy in dialysis treatment","volume":"42","author":"Cice","year":"1997","journal-title":"Cardiologia"},{"issue":"12","key":"10.1002\/14651858.CD011064.pub2-BIB0029|cit29","first-page":"1337","article-title":"Incremental doses of diltiazem in patients with coronary artery disease in end-stage renal failure maintained on hemodialysis: which is the optimal dose?","volume":"43","author":"Cice","year":"1998","journal-title":"Cardiologia"},{"issue":"4","key":"10.1002\/14651858.CD011064.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/01.ASN.0000059309.66107.FC","article-title":"Sustained-release diltiazem reduces myocardial ischemic episodes in end-stage renal disease: a double-blind, randomized, crossover, placebo-controlled trial","volume":"14","author":"Cice","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD011064.pub2-BIB0031|cit31","first-page":"141","article-title":"Efficacy of enalapril and sustained-release nifedipine in controlling blood pressure of patients on maintenance hemodialysis: observations from ongoing EDIT trial [abstract]","volume":"15","author":"Iqbal","year":"2011","journal-title":"Hemodialysis International"},{"issue":"2","key":"10.1002\/14651858.CD011064.pub2-BIB0032|cit32","first-page":"c49","article-title":"Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine","volume":"97","author":"Kojima","year":"2004","journal-title":"Nephron"},{"issue":"3","key":"10.1002\/14651858.CD011064.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1536\/ihj.51.188","article-title":"Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients","volume":"51","author":"Nakano","year":"2010","journal-title":"International Heart Journal"},{"key":"10.1002\/14651858.CD011064.pub2-BIB0034|cit34","unstructured":"Charytan D A phase IV randomized, double-blind, active-controlled, single-center study of the safety and effects on cardiac structure and function of hydralazine and isosorbide dinitrate in patients with hemodialysis dependent ESRD www.clinicaltrials.gov\/ct2\/show\/NCT02228408"},{"issue":"6","key":"10.1002\/14651858.CD011064.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/089686080502500614","article-title":"Effect of oral administration of losartan, prazosin, and verapamil on peritoneal solute transport in continuous ambulatory peritoneal dialysis patients","volume":"25","author":"Rojas-Campos","year":"2005","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD011064.pub2-BIB0036|cit36","first-page":"110A","article-title":"Oral verapamil increases ultrafiltration and peritoneal small solute clearance of CAPD patients [abstract no: SA-FC130]","volume":"16","author":"Rojas-Campos","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD011064.pub2-BIB0037|cit37","first-page":"v349","article-title":"Oral verapamil increases ultrafiltration and peritoneal small solute clearance of continuous ambulatory peritoneal dialysis (CAPD) patients [abstract no: MP448]","volume":"20","author":"Rojas-Campos","year":"2005","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD011064.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1097\/00005344-198706110-00051","article-title":"Acute hemodynamic effect of nifedipine in hypertensives with chronic renal failure: the influence of volume status","volume":"10 Suppl 10","author":"Salvetti","year":"1987","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD011064.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/10731199109117818","article-title":"Hemodialysis-related leukotriene B4 generation and neutropenia during calcium channel blockade","volume":"19","author":"Schiffl","year":"1991","journal-title":"Biomaterials, Artificial Cells, & Immobilization Biotechnology"},{"issue":"1","key":"10.1002\/14651858.CD011064.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ki.1995.41","article-title":"Effect of pre-dialysis verapamil (V) on blood pressure (BP) during hemodialysis (HD) [abstract]","volume":"37","author":"Sherman","year":"1990","journal-title":"Kidney International"},{"issue":"2","key":"10.1002\/14651858.CD011064.pub2-BIB0041|cit41","first-page":"67","article-title":"Effect of predialysis verapamil on intradialytic blood pressure in chronic hemodialysis patients","volume":"36","author":"Sherman","year":"1990","journal-title":"American Society for Artificial Internal organs"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD011064.pub2-BIB0042|cit42","first-page":"491A","article-title":"Differential blood pressure between daily morning versus evening dose of amlodipine assessed by ambulatory blood pressure monitoring [abstract]","volume":"12","author":"Singhaton","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Sept","key":"10.1002\/14651858.CD011064.pub2-BIB0043|cit43","first-page":"355A","article-title":"Supervised antihypertensive pharmacotherapy in hemodialysis patients [abstract]","volume":"11","author":"Soni","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"25","key":"10.1002\/14651858.CD011064.pub2-BIB0044|cit44","first-page":"S190","article-title":"Pathogenesis of hypertension in hemodialysis patients: a pharmacological study","volume":"34","author":"Zuccala","year":"1988","journal-title":"Kidney International - Supplement"},{"key":"10.1002\/14651858.CD011064.pub2-BIB0045|cit45","unstructured":"Cice G Cardiovascular events in hypertensive hemodialysed patients: aliskiren versus amlodipine. a randomized, double-blind study www.clinicaltrials.gov\/ct2\/show\/NCT01394770"},{"issue":"4","key":"10.1002\/14651858.CD011064.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0002-9343(03)00366-8","article-title":"Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States","volume":"115","author":"Agarwal","year":"2003","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011064.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.37757\/MR2014.V16.N2.3","article-title":"Chronic kidney disease of unknown etiology in agricultural communities","volume":"16","author":"Almaguer","year":"2014","journal-title":"MEDICC Review"},{"issue":"11","key":"10.1002\/14651858.CD011064.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1524-6175.2004.03683.x","article-title":"The role of existing and newer calcium channel blockers in the treatment of hypertension","volume":"6","author":"Basile","year":"2004","journal-title":"Journal of Clinical Hypertension"},{"issue":"6","key":"10.1002\/14651858.CD011064.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD011064.pub2-BIB0050|cit50","first-page":"767","volume-title":"Pharmacotherapy a Pathophysiologic Approach","author":"Dipiro","year":"2011"},{"issue":"1","key":"10.1002\/14651858.CD011064.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.73","article-title":"KDIGO 2012 clinical practice guidelines for the evaluation and management of chronic kidney disease","volume":"3","author":"Eknoyan","year":"2013","journal-title":"Kidney International - Supplement"},{"issue":"7650","key":"10.1002\/14651858.CD011064.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD011064.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.ki.5002773","article-title":"Calcium antagonists: do they equally protect against kidney injury?","volume":"73","author":"Hart","year":"2008","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD011064.pub2-BIB0054|cit54","unstructured":"Higgins JP Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD011064.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1525-139X.2009.00697.x","article-title":"Antihypertensive agents in hemodialysis patients: a current perspective","volume":"23","author":"Inrig","year":"2010","journal-title":"Seminars in Dialysis"},{"issue":"2","key":"10.1002\/14651858.CD011064.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.1038\/kisup.2013.3","article-title":"Current status of end-stage renal disease care in India and Pakistan","volume":"3","author":"Jha","year":"2013","journal-title":"Kidney International - Supplement"},{"issue":"2","key":"10.1002\/14651858.CD011064.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.[Erratum appears in Ann Intern Med. 2003 Oct 7;139(7):605]","volume":"139","author":"Levey","year":"2003","journal-title":"Annals of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD011064.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"e0188975","DOI":"10.1371\/journal.pone.0188975","article-title":"Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis","volume":"12","author":"Lin","year":"2017","journal-title":"Plos One"},{"key":"10.1002\/14651858.CD011064.pub2-BIB0059|cit59","volume-title":"Prevalance of peripheral arterial disease among chronic kidney disease patients at Kenyatta National Hospital [MMed Thesis]","author":"Maritim","year":"2007"},{"issue":"2","key":"10.1002\/14651858.CD011064.pub2-BIB0060|cit60","first-page":"c63","article-title":"Analytical review of the evidence for renoprotection by renin-angiotensin-aldosterone system blockade in chronic kidney disease - a call for caution","volume":"113","author":"Onuigbo","year":"2009","journal-title":"Nephron"},{"key":"10.1002\/14651858.CD011064.pub2-BIB0061|cit61","volume-title":"Prevalence of hypertension and adequacy of its control in chronic kidney disease patients at the renal clinic at Kenyatta National Hospital [MMed Thesis]","author":"Rajula","year":"2009"},{"issue":"5","key":"10.1002\/14651858.CD011064.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1185\/030079908X291921","article-title":"Angiotensin receptor blockers: RAAS blockade and renoprotection","volume":"24","author":"Ruilope","year":"2008","journal-title":"Current Medical Research & Opinion"},{"key":"10.1002\/14651858.CD011064.pub2-BIB0063|cit63","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011064.pub2-BIB0064|cit64","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Deeks JJ Glasziou P Guyatt GH Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD011064.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1524-6175.2006.04482.x","article-title":"Calcium channel blocker class heterogeneity; select aspects of pharmacokinetics and pharmacodynamics","volume":"7","author":"Sica","year":"2005","journal-title":"Journal of Clinical Hypertension"},{"key":"10.1002\/14651858.CD011064.pub2-BIB0066|cit66","unstructured":"Standardised outcomes in nephrology www.songinitiative.org\/projects\/song-hd\/"},{"key":"10.1002\/14651858.CD011064.pub2-BIB0067|cit67","unstructured":"Standardised outcomes in nephrology www.songinitiative.org\/projects\/song-pd\/"},{"issue":"1","key":"10.1002\/14651858.CD011064.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MNH.0b013e32834db3e4","article-title":"Interdialytic ambulatory blood pressure in patients with intradialytic hypertension","volume":"21","author":"Van Buren","year":"2012","journal-title":"Current Opinion in Nephrology & Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD011064.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"61","DOI":"10.37757\/MR2014.V16.N2.10","article-title":"Update on uncertain etiology of chronic kidney disease in Sri Lanka's north central dry zone","volume":"16","author":"Wanigasuriya","year":"2014","journal-title":"MEDICC Review"},{"issue":"4","key":"10.1002\/14651858.CD011064.pub2-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011064","article-title":"Calcium channel blockers for people with chronic kidney disease requiring dialysis","author":"Mugendi","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:20:34Z","timestamp":1788844834000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011064.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":70,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011064.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}